These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31551111)

  • 1. Coordinating a new approach to basic research into Parkinson's disease.
    Schekman R; Riley EA
    Elife; 2019 Sep; 8():. PubMed ID: 31551111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open science takes on Parkinson's disease.
    Riley EA; Schekman R
    Elife; 2021 Feb; 10():. PubMed ID: 33629954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Researchers unite to improve Parkinson's drug discovery.
    Dolgin E
    Nat Med; 2010 Mar; 16(3):247. PubMed ID: 20208492
    [No Abstract]   [Full Text] [Related]  

  • 4. Bibliometric analysis on global Parkinson's disease research trends during 1991-2006.
    Li T; Ho YS; Li CY
    Neurosci Lett; 2008 Aug; 441(3):248-52. PubMed ID: 18582532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathophysiology of Parkinson's disease: an update].
    Tremblay L
    Bull Acad Natl Med; 2010 Oct; 194(7):1321-31; discussion 1331-2. PubMed ID: 22043627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI).
    Nalls MA; Keller MF; Hernandez DG; Chen L; Stone DJ; Singleton AB;
    Mov Disord; 2016 Jan; 31(1):79-85. PubMed ID: 26268663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's: symptoms, treatments and research.
    Heisters D
    Br J Nurs; 2011 May 13-26; 20(9):548-54. PubMed ID: 21647015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the progression of Parkinson's disease: a metabolic network approach.
    Eckert T; Tang C; Eidelberg D
    Lancet Neurol; 2007 Oct; 6(10):926-32. PubMed ID: 17884682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients.
    Swanson CR; Berlyand Y; Xie SX; Alcalay RN; Chahine LM; Chen-Plotkin AS
    Mov Disord; 2015 Oct; 30(12):1648-56. PubMed ID: 26207725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Think positively": Parkinson's disease, biomedicine, and hope in contemporary Germany.
    Metzler I; Just P
    Health (London); 2018 Sep; 22(5):483-499. PubMed ID: 28637363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
    Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
    Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hunt for a cure for Parkinson's disease.
    Andersen JK; Kumar J; Srinivas B; Kaur D; Hsu M; Rajagopalan S
    Sci Aging Knowledge Environ; 2001 Oct; 2001(1):re1. PubMed ID: 14602952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
    Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
    J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of nonhuman primate models to understand processes in Parkinson's disease.
    Blesa J; Trigo-Damas I; Del Rey NL; Obeso JA
    J Neural Transm (Vienna); 2018 Mar; 125(3):325-335. PubMed ID: 28357564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's Disease Research Education and Clinical Centers (PADRECC): background and overview.
    Diaz N; Bronstein JM
    NeuroRehabilitation; 2005; 20(3):153-60. PubMed ID: 16340096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-based rehabilitation for Parkinson's disease: from neurons to neighborhoods.
    Hirsch MA
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S114-7. PubMed ID: 20082969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities.
    Berg D; Lang AE; Postuma RB; Maetzler W; Deuschl G; Gasser T; Siderowf A; Schapira AH; Oertel W; Obeso JA; Olanow CW; Poewe W; Stern M
    Lancet Neurol; 2013 May; 12(5):514-24. PubMed ID: 23582175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus document on European brain research.
    Olesen J; Baker MG; Freund T; di Luca M; Mendlewicz J; Ragan I; Westphal M
    J Neurol Neurosurg Psychiatry; 2006 Aug; 77 Suppl 1(Suppl 1):i1-49. PubMed ID: 16845120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
    Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dance for Parkinson's: a new framework for research on its physical, mental, emotional, and social benefits.
    McGill A; Houston S; Lee RY
    Complement Ther Med; 2014 Jun; 22(3):426-32. PubMed ID: 24906580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.